en

PRODUCT DETAIL

Plerixafor Accord 20 mg/ml injekčný roztok

Code 2652E
MA number EU/1/22/1701/001
Product Form: sol inj 1x1,2 ml/24 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Accord Healthcare S.L.U, Spain
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 Immunomodulators/-stimulants
L03A Immunostimulants
L03AX Other immunostimulants
L03AX16 Plerixafor
Shelf life: 24
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.12.2022
Validity: 16.12.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 31.05.2024
eu-flag.png sk-flag.png